LURBINECTEDIN

LURBINECTEDIN was reported 1169 times

LURBINECTEDIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINE LACTIC ACID INCREASED 1 0.2500
1 NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC 1 0.0769
2 GASTROINTESTINAL NEUROENDOCRINE CARCINOMA 1 0.0345
3 EXPOSURE KERATITIS 1 0.0333
4 PARATRACHEAL LYMPHADENOPATHY 3 0.0246
5 PNEUMOBILIA 4 0.0241
6 SMALL CELL LUNG CANCER METASTATIC 4 0.0113
7 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 1 0.0108
8 CHRONIC PIGMENTED PURPURA 2 0.0103
9 SMALL CELL LUNG CANCER EXTENSIVE STAGE 1 0.0087
10 KLEBSIELLA URINARY TRACT INFECTION 2 0.0075
11 ADMINISTRATION SITE IRRITATION 1 0.0071
12 SMALL CELL LUNG CANCER 10 0.0066
13 PROCEDURAL PNEUMOTHORAX 1 0.0065
14 ADMINISTRATION SITE EXTRAVASATION 6 0.0060
15 INFUSION SITE VESICLES 3 0.0057
16 STOMA SITE ULCER 1 0.0056
17 EXTRAVASATION 23 0.0056
18 ARM AMPUTATION 1 0.0055
19 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
20 MEDIASTINAL DISORDER 2 0.0053
21 IMMUNE-MEDIATED ARTHRITIS 2 0.0052
22 ALKALOSIS 2 0.0052
23 ANAEMIA FOLATE DEFICIENCY 1 0.0052
24 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
25 TISSUE INJURY 2 0.0046
26 NEUTROPENIC INFECTION 4 0.0042
27 NEUROENDOCRINE CARCINOMA METASTATIC 1 0.0041
28 LIVER CARCINOMA RUPTURED 1 0.0040
29 WOUND TREATMENT 1 0.0039
30 INFUSION SITE THROMBOSIS 1 0.0037
31 LABILE HYPERTENSION 1 0.0036
32 TISSUE INFILTRATION 1 0.0034
33 VASCULAR PAIN 3 0.0031
34 SMALL CELL CARCINOMA 1 0.0029
35 BILIARY DILATATION 4 0.0027
36 CATHETER SITE RELATED REACTION 2 0.0027
37 PNEUMONIA PSEUDOMONAL 4 0.0026
38 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
39 LIMB AMPUTATION 1 0.0025
40 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
41 PHLEBITIS 12 0.0023
42 IMMUNE-MEDIATED NEPHRITIS 1 0.0021
43 VEIN DISCOLOURATION 1 0.0021
44 WOUND NECROSIS 1 0.0021
45 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
46 RADIATION NECROSIS 1 0.0017
47 SUPERIOR VENA CAVA SYNDROME 1 0.0017
48 INFUSION SITE EXTRAVASATION 10 0.0016
49 BILIARY OBSTRUCTION 2 0.0015
50 KLEBSIELLA TEST POSITIVE 1 0.0015
51 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
52 PNEUMOTHORAX SPONTANEOUS 1 0.0015
53 SOFT TISSUE NECROSIS 1 0.0015
54 NEUROENDOCRINE CARCINOMA 1 0.0014
55 THROMBOPHLEBITIS 5 0.0014
56 INFUSION SITE INFLAMMATION 1 0.0014
57 CATHETER SITE ERYTHEMA 3 0.0014
58 HAEMATOTOXICITY 13 0.0014
59 TUMOUR LYSIS SYNDROME 12 0.0014
60 NORMOCYTIC ANAEMIA 2 0.0014
61 INFUSION SITE REACTION 4 0.0013
62 MYOPERICARDITIS 1 0.0013
63 VEIN DISORDER 6 0.0012
64 HYPERTRANSAMINASAEMIA 8 0.0011
65 INFUSION SITE DISCOLOURATION 1 0.0011
66 JUGULAR VEIN THROMBOSIS 2 0.0011
67 MUSCLE NECROSIS 1 0.0011
68 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
69 LUNG CANCER METASTATIC 3 0.0010
70 TELANGIECTASIA 1 0.0010
71 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
72 INFUSION SITE DISCOMFORT 1 0.0010
73 FEBRILE BONE MARROW APLASIA 4 0.0009
74 INFUSION SITE BRUISING 2 0.0009
75 DISEASE PROGRESSION 108 0.0009
76 PSEUDOMEMBRANOUS COLITIS 2 0.0009
77 MYOCARDIAL INJURY 1 0.0009
78 CERVICAL VERTEBRAL FRACTURE 3 0.0009
79 PALMAR ERYTHEMA 1 0.0009
80 RADIATION SKIN INJURY 1 0.0009
81 FEBRILE INFECTION 1 0.0008
82 NEUTROPENIC SEPSIS 6 0.0008
83 ESCHERICHIA TEST POSITIVE 1 0.0008
84 GASTROINTESTINAL TOXICITY 4 0.0008
85 CHRONIC RESPIRATORY FAILURE 1 0.0008
86 PANNICULITIS 2 0.0008
87 INFUSION SITE WARMTH 1 0.0008
88 INFUSION SITE SWELLING 5 0.0008
89 PRERENAL FAILURE 1 0.0007
90 HOSPICE CARE 7 0.0007
91 FEBRILE NEUTROPENIA 47 0.0007
92 PNEUMONITIS 19 0.0007
93 ACUTE ABDOMEN 1 0.0007
94 INFUSION SITE INDURATION 1 0.0007
95 CYTOPENIA 8 0.0007
96 STOMA SITE HAEMORRHAGE 1 0.0006
97 MYELITIS 1 0.0006
98 PNEUMONIA VIRAL 2 0.0006
99 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
100 NEUTROPENIA 82 0.0006
101 TROPONIN I INCREASED 1 0.0006
102 NEPHRITIS 2 0.0006
103 ENTEROBACTER INFECTION 1 0.0006
104 INFUSION SITE ERYTHEMA 5 0.0006
105 INJECTION SITE OEDEMA 1 0.0006
106 TREATMENT DELAYED 1 0.0006
107 SKIN NECROSIS 3 0.0006
108 FAILURE TO THRIVE 3 0.0006
109 PSEUDOMONAL SEPSIS 1 0.0006
110 SKIN WEEPING 2 0.0006
111 MONOPARESIS 1 0.0006
112 SOFT TISSUE INFECTION 1 0.0005
113 PNEUMONIA KLEBSIELLA 1 0.0005
114 AMYLASE INCREASED 2 0.0005
115 LYMPH NODE PAIN 1 0.0005
116 THROMBOCYTOPENIA 60 0.0005
117 MYELOSUPPRESSION 19 0.0005
118 MECHANICAL VENTILATION 1 0.0005
119 INJECTION SITE REACTION 36 0.0005
120 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
121 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
122 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
123 HYPOPHYSITIS 1 0.0005
124 INJECTION SITE NECROSIS 1 0.0005
125 CAPILLARY LEAK SYNDROME 1 0.0005
126 NEUTROPENIC COLITIS 1 0.0005
127 HYPERBILIRUBINAEMIA 5 0.0005
128 SUBILEUS 1 0.0005
129 BODY TEMPERATURE FLUCTUATION 1 0.0005
130 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
131 EAR SWELLING 1 0.0005
132 ANAEMIA MACROCYTIC 1 0.0005
133 NEUTROPHIL COUNT DECREASED 19 0.0005
134 INFUSION SITE PAIN 6 0.0005
135 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
136 PRODUCT PREPARATION ISSUE 3 0.0005
137 PANCYTOPENIA 25 0.0004
138 VASCULAR DEVICE INFECTION 2 0.0004
139 METASTASES TO MENINGES 1 0.0004
140 NEUROLOGICAL DECOMPENSATION 1 0.0004
141 PERFORMANCE STATUS DECREASED 2 0.0004
142 MUCOSAL INFLAMMATION 11 0.0004
143 THERAPY CHANGE 4 0.0004
144 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
145 PERSECUTORY DELUSION 1 0.0004
146 TOXIC ENCEPHALOPATHY 2 0.0004
147 CANCER PAIN 1 0.0004
148 COMPARTMENT SYNDROME 1 0.0004
149 RADICULOPATHY 1 0.0004
150 CHOLECYSTITIS INFECTIVE 1 0.0004
151 LYMPHOPENIA 5 0.0004
152 PARAPLEGIA 1 0.0003
153 DYSPNOEA AT REST 1 0.0003
154 HAEMOTHORAX 1 0.0003
155 MYOSITIS 3 0.0003
156 HEPATITIS CHOLESTATIC 2 0.0003
157 ADRENAL INSUFFICIENCY 4 0.0003
158 CHOLANGITIS 2 0.0003
159 COLITIS 12 0.0003
160 HEPATITIS B REACTIVATION 1 0.0003
161 HEPATITIS ACUTE 2 0.0003
162 BACTERIAL SEPSIS 1 0.0003
163 LISTLESS 1 0.0003
164 SEPTIC SHOCK 13 0.0003
165 METASTASES TO SPINE 1 0.0003
166 CLOSTRIDIAL INFECTION 1 0.0003
167 LEFT VENTRICULAR FAILURE 1 0.0003
168 DEVICE OCCLUSION 4 0.0003
169 EMBOLIC STROKE 1 0.0003
170 METASTASIS 2 0.0003
171 RASH MACULO-PAPULAR 6 0.0003
172 KETOACIDOSIS 2 0.0003
173 PROTEIN TOTAL DECREASED 1 0.0003
174 ACIDOSIS 2 0.0003
175 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
176 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
177 HYPOALBUMINAEMIA 2 0.0003
178 THERAPY PARTIAL RESPONDER 4 0.0003
179 BLOOD ALBUMIN DECREASED 2 0.0003
180 OESOPHAGEAL CANDIDIASIS 1 0.0003
181 BONE MARROW FAILURE 5 0.0002
182 SHOCK HAEMORRHAGIC 2 0.0002
183 RESPIRATORY DEPRESSION 3 0.0002
184 SMALL INTESTINAL OBSTRUCTION 3 0.0002
185 HICCUPS 2 0.0002
186 INJECTION SITE EXTRAVASATION 3 0.0002
187 EMBOLISM 2 0.0002
188 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
189 ANAEMIA 45 0.0002
190 PLATELET COUNT DECREASED 25 0.0002
191 HEPATIC LESION 1 0.0002
192 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
193 METASTASES TO LIVER 4 0.0002
194 ABDOMINAL ABSCESS 1 0.0002
195 BLOOD CREATINE INCREASED 1 0.0002
196 TRANSAMINASES INCREASED 5 0.0002
197 ILEUS PARALYTIC 1 0.0002
198 BRAIN NEOPLASM MALIGNANT 1 0.0002
199 DRUG-INDUCED LIVER INJURY 7 0.0002
200 UROSEPSIS 2 0.0002
201 LOCALISED OEDEMA 1 0.0002
202 HYPOVOLAEMIC SHOCK 1 0.0002
203 ORGANISING PNEUMONIA 1 0.0002
204 INJECTION SITE INFLAMMATION 1 0.0002
205 CYTOKINE RELEASE SYNDROME 4 0.0002
206 ERYSIPELAS 1 0.0002
207 SEPSIS 22 0.0002
208 AMMONIA INCREASED 1 0.0002
209 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
210 CEREBRAL ISCHAEMIA 1 0.0002
211 TENDERNESS 2 0.0002
212 ACUTE KIDNEY INJURY 29 0.0002
213 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
214 LIVER FUNCTION TEST INCREASED 4 0.0002
215 BLOOD BILIRUBIN INCREASED 5 0.0002
216 DEAFNESS UNILATERAL 1 0.0002
217 NECROSIS 1 0.0002
218 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
219 SKIN INFECTION 2 0.0002
220 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
221 CHOLECYSTITIS ACUTE 1 0.0002
222 GRANULOCYTOPENIA 1 0.0002
223 NEUROLOGICAL SYMPTOM 1 0.0002
224 DEATH 150 0.0002
225 SKIN ATROPHY 1 0.0002
226 METABOLIC DISORDER 1 0.0002
227 ASCITES 5 0.0002
228 LYMPHOCYTE COUNT DECREASED 3 0.0002
229 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
230 BACTERAEMIA 2 0.0002
231 CHOLECYSTITIS 2 0.0002
232 RHABDOMYOLYSIS 7 0.0002
233 INFUSION RELATED REACTION 11 0.0002
234 PLATELET COUNT ABNORMAL 1 0.0002
235 INJECTION SITE VESICLES 1 0.0002
236 RESPIRATORY FAILURE 12 0.0002
237 DERMATITIS ACNEIFORM 1 0.0002
238 ENCEPHALOPATHY 4 0.0002
239 PIGMENTATION DISORDER 1 0.0002
240 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
241 LEUKOPENIA 8 0.0002
242 HEPATIC CYTOLYSIS 2 0.0002
243 ACUTE RESPIRATORY FAILURE 3 0.0002
244 RESPIRATORY TRACT INFECTION 4 0.0002
245 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
246 RESPIRATION ABNORMAL 1 0.0001
247 RESPIRATORY DISTRESS 4 0.0001
248 INTERSTITIAL LUNG DISEASE 7 0.0001
249 ENCEPHALITIS 1 0.0001
250 LARGE INTESTINE PERFORATION 1 0.0001
251 HYPOMAGNESAEMIA 2 0.0001
252 DEFAECATION URGENCY 1 0.0001
253 HYPONATRAEMIA 8 0.0001
254 HYPOXIA 5 0.0001
255 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
256 HEPATOCELLULAR INJURY 2 0.0001
257 THERMAL BURN 1 0.0001
258 CELLULITIS 7 0.0001
259 MYELODYSPLASTIC SYNDROME 2 0.0001
260 HYPERTHYROIDISM 2 0.0001
261 HYPOKINESIA 2 0.0001
262 HYPOPHOSPHATAEMIA 1 0.0001
263 HEPATOTOXICITY 3 0.0001
264 HEPATIC FUNCTION ABNORMAL 5 0.0001
265 PANCREATITIS ACUTE 3 0.0001
266 BLOOD COUNT ABNORMAL 2 0.0001
267 PLEURAL EFFUSION 8 0.0001
268 LIPASE INCREASED 1 0.0001
269 DEVICE RELATED INFECTION 2 0.0001
270 MUSCULOSKELETAL CHEST PAIN 2 0.0001
271 PULMONARY HAEMORRHAGE 1 0.0001
272 GASTROINTESTINAL INFLAMMATION 1 0.0001
273 SCIATICA 2 0.0001
274 MYASTHENIA GRAVIS 1 0.0001
275 FRUSTRATION TOLERANCE DECREASED 1 0.0001
276 BLOOD CREATININE INCREASED 8 0.0001
277 ESCHERICHIA INFECTION 1 0.0001
278 SECOND PRIMARY MALIGNANCY 1 0.0001
279 ASTHENIA 45 0.0001
280 HAEMATEMESIS 3 0.0001
281 HYPOPHAGIA 3 0.0001
282 HOSPITALISATION 18 0.0001
283 PRODUCT CONTAINER ISSUE 1 0.0001
284 PSEUDOMONAS INFECTION 1 0.0001
285 BLOOD MAGNESIUM DECREASED 1 0.0001
286 MUSCLE STRAIN 1 0.0001
287 PYELONEPHRITIS 1 0.0001
288 DEVICE DEFECTIVE 2 0.0001
289 DELIRIUM 4 0.0001
290 NEOPLASM PROGRESSION 4 0.0001
291 URINE OUTPUT DECREASED 1 0.0001
292 NAIL DISORDER 1 0.0001
293 LUNG INFILTRATION 1 0.0001
294 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
295 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
296 HAEMOLYTIC ANAEMIA 1 0.0001
297 GASTROINTESTINAL INFECTION 1 0.0001
298 PNEUMONIA BACTERIAL 1 0.0001
299 AGRANULOCYTOSIS 2 0.0001
300 HAEMOPTYSIS 3 0.0001
301 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
302 NEPHROPATHY 1 0.0001
303 BLISTER 6 0.0001
304 FLANK PAIN 1 0.0001
305 INTESTINAL OBSTRUCTION 4 0.0001
306 CONSTIPATION 23 0.0001
307 CHOLESTASIS 2 0.0001
308 ACUTE MYOCARDIAL INFARCTION 3 0.0001
309 ARTHRITIS 8 0.0001
310 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
311 FULL BLOOD COUNT DECREASED 2 0.0001
312 HYPOTHERMIA 1 0.0001
313 PRODUCT PREPARATION ERROR 2 0.0001
314 LUNG NEOPLASM MALIGNANT 4 0.0001
315 FULL BLOOD COUNT ABNORMAL 1 0.0001
316 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
317 HYPOTHYROIDISM 3 0.0001
318 OFF LABEL USE 82 0.0001
319 CHOLELITHIASIS 3 0.0001
320 VOMITING 43 0.0001
321 MELAENA 2 0.0001
322 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
323 PNEUMONIA 29 0.0001
324 NAUSEA 70 0.0001
325 IMPAIRED DRIVING ABILITY 1 0.0001
326 LETHARGY 5 0.0001
327 GASTRIC HAEMORRHAGE 1 0.0001
328 HYPOKALAEMIA 4 0.0001
329 PERICARDIAL EFFUSION 2 0.0001
330 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
331 SPINAL PAIN 1 0.0001
332 COVID-19 PNEUMONIA 1 0.0001
333 ATAXIA 1 0.0001
334 C-REACTIVE PROTEIN INCREASED 3 0.0001
335 NOCTURIA 1 0.0001
336 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
337 HYPERCALCAEMIA 1 0.0001
338 HEPATITIS 2 0.0001
339 THERAPY CESSATION 4 0.0001
340 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
341 RENAL FAILURE 10 0.0001
342 JAUNDICE 2 0.0001
343 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
344 NEUROPATHY PERIPHERAL 7 0.0001
345 HEPATIC ENZYME INCREASED 5 0.0001
346 PERIPHERAL COLDNESS 1 0.0001
347 DIVERTICULITIS 2 0.0001
348 FATIGUE 56 0.0001
349 INTENTIONAL DOSE OMISSION 2 0.0001
350 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
351 DECREASED APPETITE 16 0.0001
352 HAEMOGLOBIN DECREASED 7 0.0001
353 LABORATORY TEST ABNORMAL 2 0.0001
354 COUGH 19 0.0001
355 THERAPY NON-RESPONDER 3 0.0001
356 HEPATIC FAILURE 2 0.0001
357 STOMATITIS 4 0.0001
358 DEVICE ADHESION ISSUE 1 0.0001
359 EJECTION FRACTION DECREASED 1 0.0001
360 ACUTE MYELOID LEUKAEMIA 1 0.0001
361 HEAD INJURY 2 0.0001
362 PULMONARY EMBOLISM 6 0.0001
363 PNEUMOTHORAX 1 0.0001
364 HYPOGLYCAEMIA 3 0.0001
365 ATRIAL FIBRILLATION 6 0.0001
366 LUNG DISORDER 3 0.0001
367 COAGULOPATHY 1 0.0001
368 PERICARDITIS 1 0.0001
369 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
370 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
371 MUSCULOSKELETAL PAIN 3 0.0001
372 COLD SWEAT 1 0.0001
373 ABDOMINAL PAIN 13 0.0001
374 DYSURIA 2 0.0001
375 CONJUNCTIVITIS 1 0.0001
376 DYSPNOEA EXERTIONAL 2 0.0001
377 BLOOD SODIUM DECREASED 1 0.0001
378 HYPOCALCAEMIA 1 0.0001
379 DEHYDRATION 7 0.0001
380 PRESCRIBED OVERDOSE 1 0.0001
381 DYSPNOEA 29 0.0001
382 BONE PAIN 3 0.0001
383 DISABILITY 1 0.0001
384 DISORIENTATION 2 0.0001
385 HAEMATOCRIT DECREASED 1 0.0001
386 COMPLICATION OF DEVICE INSERTION 1 0.0001
387 SPINAL FRACTURE 1 0.0000
388 PRODUCT ADMINISTRATION ERROR 1 0.0000
389 TASTE DISORDER 1 0.0000
390 DIARRHOEA 31 0.0000
391 RENAL IMPAIRMENT 4 0.0000
392 MYALGIA 8 0.0000
393 RETCHING 1 0.0000
394 HYPOACUSIS 2 0.0000
395 SWELLING FACE 3 0.0000
396 PRODUCT DISPENSING ERROR 1 0.0000
397 PERIPHERAL SWELLING 7 0.0000
398 SNEEZING 1 0.0000
399 CHROMATURIA 1 0.0000
400 MUSCULAR WEAKNESS 5 0.0000
401 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
402 PYREXIA 15 0.0000
403 WEIGHT DECREASED 12 0.0000
404 INFECTION 6 0.0000
405 DRUG INTOLERANCE 4 0.0000
406 LOCALISED INFECTION 1 0.0000
407 NEURALGIA 1 0.0000
408 LIVER INJURY 1 0.0000
409 DYSGEUSIA 3 0.0000
410 COVID-19 7 0.0000
411 UNEVALUABLE EVENT 3 0.0000
412 UNRESPONSIVE TO STIMULI 1 0.0000
413 BACK PAIN 9 0.0000
414 SKIN ULCER 1 0.0000
415 NO ADVERSE EVENT 7 0.0000
416 EXPOSURE VIA SKIN CONTACT 1 0.0000
417 PARAESTHESIA 6 0.0000
418 JOINT STIFFNESS 1 0.0000
419 GASTRITIS 1 0.0000
420 THROMBOSIS 3 0.0000
421 LIMB INJURY 1 0.0000
422 PROCEDURAL PAIN 1 0.0000
423 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
424 ALOPECIA 7 0.0000
425 OXYGEN SATURATION DECREASED 2 0.0000
426 RED BLOOD CELL COUNT DECREASED 1 0.0000
427 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
428 DYSPHONIA 2 0.0000
429 HYPOAESTHESIA 5 0.0000
430 OEDEMA PERIPHERAL 4 0.0000
431 FEELING HOT 2 0.0000
432 CHEST PAIN 6 0.0000
433 GYNAECOMASTIA 1 0.0000
434 SWELLING 3 0.0000
435 SWOLLEN TONGUE 1 0.0000
436 CYSTITIS 1 0.0000
437 HYPERHIDROSIS 4 0.0000
438 PRODUCT DOSE OMISSION ISSUE 9 0.0000
439 VISUAL ACUITY REDUCED 1 0.0000
440 LIP SWELLING 1 0.0000
441 NEOPLASM MALIGNANT 2 0.0000
442 CHEST DISCOMFORT 3 0.0000
443 HAEMATURIA 1 0.0000
444 HYPERKALAEMIA 1 0.0000
445 DEVICE MALFUNCTION 2 0.0000
446 LYMPHADENOPATHY 1 0.0000
447 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
448 CHRONIC KIDNEY DISEASE 2 0.0000
449 SEIZURE 3 0.0000
450 PALPITATIONS 3 0.0000
451 HYPOTENSION 5 0.0000
452 CARDIAC FAILURE 2 0.0000
453 ERYTHEMA 5 0.0000
454 TREATMENT FAILURE 2 0.0000
455 POLLAKIURIA 1 0.0000
456 PAIN IN EXTREMITY 7 0.0000
457 URINARY TRACT INFECTION 4 0.0000
458 LIVER DISORDER 1 0.0000
459 TACHYCARDIA 2 0.0000
460 PULMONARY OEDEMA 1 0.0000
461 DEVICE ISSUE 2 0.0000
462 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
463 MEMORY IMPAIRMENT 3 0.0000
464 SKIN DISCOLOURATION 1 0.0000
465 DISEASE RECURRENCE 1 0.0000
466 PRODUCTIVE COUGH 1 0.0000
467 RASH ERYTHEMATOUS 1 0.0000
468 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
469 CONTUSION 2 0.0000
470 SYNCOPE 2 0.0000
471 FLUID RETENTION 1 0.0000
472 ILLNESS 2 0.0000
473 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
474 INFLAMMATION 1 0.0000
475 PANCREATITIS 1 0.0000
476 TREATMENT NONCOMPLIANCE 1 0.0000
477 DEPENDENCE 1 0.0000
478 DIZZINESS 9 0.0000
479 MEDICATION ERROR 1 0.0000
480 TOXICITY TO VARIOUS AGENTS 3 0.0000
481 EYE PAIN 1 0.0000
482 ASTHMA 2 0.0000
483 HERPES ZOSTER 1 0.0000
484 SURGERY 1 0.0000
485 NASAL CONGESTION 1 0.0000
486 DISCOMFORT 1 0.0000
487 INJECTION SITE ERYTHEMA 2 0.0000
488 PRODUCT USE ISSUE 3 0.0000
489 DEEP VEIN THROMBOSIS 1 0.0000
490 AMNESIA 1 0.0000
491 FALL 5 0.0000
492 DRY SKIN 2 0.0000
493 BURNING SENSATION 1 0.0000
494 SLEEP DISORDER 1 0.0000
495 HYPERTENSION 3 0.0000
496 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
497 BRONCHITIS 1 0.0000
498 CONDITION AGGRAVATED 4 0.0000
499 DIABETES MELLITUS 1 0.0000
500 DRUG DOSE OMISSION BY DEVICE 1 0.0000
501 DRUG INTERACTION 2 0.0000
502 PROSTATE CANCER 1 0.0000
503 CONFUSIONAL STATE 2 0.0000
504 DRY MOUTH 1 0.0000
505 INFLUENZA LIKE ILLNESS 1 0.0000
506 ABDOMINAL DISCOMFORT 2 0.0000
507 CEREBROVASCULAR ACCIDENT 2 0.0000
508 INTENTIONAL PRODUCT MISUSE 1 0.0000
509 MALAISE 5 0.0000
510 INSOMNIA 3 0.0000
511 GASTROINTESTINAL DISORDER 1 0.0000
512 DRUG INEFFECTIVE 14 0.0000
513 DYSPHAGIA 1 0.0000
514 PRURITUS 4 0.0000
515 HEART RATE INCREASED 1 0.0000
516 SOMNOLENCE 2 0.0000
517 ABDOMINAL PAIN UPPER 2 0.0000
518 DEPRESSION 2 0.0000
519 JOINT SWELLING 1 0.0000
520 PAIN 5 0.0000
521 VISUAL IMPAIRMENT 1 0.0000
522 LOSS OF CONSCIOUSNESS 1 0.0000
523 ANXIETY 2 0.0000
524 RASH 3 0.0000
525 HEADACHE 4 0.0000
526 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
527 MUSCLE SPASMS 1 0.0000
528 BLOOD GLUCOSE INCREASED 1 0.0000
529 GAIT DISTURBANCE 1 0.0000
530 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
531 ARTHRALGIA 2 0.0000
532 OVERDOSE 1 0.0000
533 WEIGHT INCREASED 1 0.0000
534 FEELING ABNORMAL 1 0.0000
535 INJECTION SITE PAIN 1 0.0000